Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_assertion description "[Molecular therapeutic approaches, for example, those directed against the fusion protein BCR-ABL with ABL-tyrosine kinase inhibitor, are on the way to creating a new avenue for the treatment of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_assertion evidence source_evidence_literature NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_assertion SIO_000772 11049022 NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_assertion wasDerivedFrom befree-20140225 NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_assertion wasGeneratedBy ECO_0000203 NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.
- befree-20140225 importedOn "2014-02-25" NP294057.RA8cww4AUErWn9Xu45Oy8HAeyKn1YLd1pIdZMIr1GfY_s130_provenance.